If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
INTERVENTIONAL
CARDIOLOGY
ISSN 2053-423X Vol 5.1 • July 2017 • europeanmedical-journal.com
INSIDE
Review of
EuroPCR 2017
Paris, France
CONTENTS
EDITORIAL BOARD...................................................................................................................................... 4
CONGRESS REVIEW.................................................................................................................................... 12
• Review of the EuroPCR congress, held in Paris, France, 16th–19th May 2017
INTERVIEWS WITH EMJ INTERVENTIONAL CARDIOLOGY EDITORIAL BOARD.......................... 27
ABSTRACT REVIEWS.................................................................................................................................. 34
ARTICLES
• EDITOR’S PICK: CURRENT STATUS OF FULLY AUTOMATED
INTERVENTIONAL CARDIOLOGY ISSN 2053-423X
CONTENTS EDITORIAL BOARD.......................
INTERVENTIONAL CARDIOLOGY • REPAIR OF CONGENI
EDITORIAL BOARD EDITOR-IN-CHIEF Dr Alexandre Av
INTERVENTIONAL CARDIOLOGY AIMS AND SCOPE •
INTERVENTIONAL CARDIOLOGY 5.1 JULY 2017 Director
Welcome We at EMJ would like to bid you a warm
SUBSCRIBE FREE TO OUR YOUTUBE CHANNEL www.youtube
Foreword Dr Pierfrancesco Agost
European Medical Journal 2.1 2017
FEATURE Climate Change: What Can Doctors Do? •
EUROPCR ANNUAL CONGRESS 2017 PALAIS DES CONGRÈS
his year’s EuroPCR congress was held in th
Effect of Bivalirudin Versus Unfractionated Hepar
size (N=78), should be acknowledged and the
As this was a pilot trial, limitations should be
Existing patients will continue to be monitored t
“The clinical symptoms and wellbeing of pati
Significant differences in event rate were ob
Excellent Clinical Outcomes Displayed for Two Tra
“The FORWARD results with a large patient cohort
Quality of life was also found to be lower at 30
This is a clinical breakthrough as no other BRS t
Encouraging Trial Results for First Fully-Dissolv
europeanmedical-journal.com EUROPEAN UNION Invest
Magdy Abdelhamid Professor of Cardiovascular Med
I think it is important for healthcare profession
Sanjog Kalra Associate Director, Interventional
As the field of interventional cardiology turns 40
me in the use of cutting-edge technologies and te
Q: How do you believe policy makers and funding b
Would you like to write for the EMJ blog? Interac
Abstract Reviews CLINICAL USE OF FFRCT
EUROPCR 2017 ICA and FFR examination. We de
Abstract Reviews infarction. Most measurements w
EUROPCR 2017 of the surgical valve.2 The objecti
Abstract Reviews THE NEW SMART NEEDLE
EUROPCR 2017 due to the high success rate, indep
Abstract Reviews Keywords: Tricuspid regurgitati
EUROPCR 2017 At 30 days, 73% of patients w
Abstract Reviews frequent among ticagrelor-t
EUROPCR 2017 3. Gaubert M et al. Effect of ticag
Abstract Reviews that the observed survival woul
EUROPCR 2017 In conclusion, the survival out
Abstract Reviews During the 10-year follow-up, 1
EUROPEAN MEDICAL JOURNAL provides influential arti
EDITOR’S PICK This paper, courtesy o
LVEF values could occur due to measurement
A EDV: 89 mL B EDV: 75 mL 75 mL E
to a small or normal-sized left ventricle. Althou
A B C 4C 2C 3C
of LV function.7 To overcome this problem and wid
REFERENCES 1. Nishimura RA et al. 2014 AHA/ACC g
STENT OR SCAFFOLD THROMBOSIS: PAST, CURR
including drug-coated balloons or bioresorbab
and ISR. The everolimus-eluting stent has b
RCA
including not only ST but also delayed late lumin
incidence of major adverse cardiac, as well
20. Cheneau E et al. Asymptomatic late stent thr
REPAIR OF CONGENITAL HEART DEFECTS: ESSENTIA
ATRIAL SEPTAL DEFECT ASD is the second most comm
Internationally recognised indications for AS
has a high implantation success rate (96.6%) with
A B C D Figure 1: Surgical techniques in coarc
and imaging criteria.8 Repair is indicated in pat
symptomatic patients, those with RV dysfunction,
Heart J. 2010;31(23):2915-57. 9. Warnes CA et
112(8):729-31. 48. Ng AS et al. Patent ductus art
IS THERE AN OPTIMAL DURATION OF
safety and efficacy of different durations of DAP
Table 2: Randomised controlled trials comparing 1
Table 2 continued. Studies (ClinicalTrials.gov Id
major bleeding with 24 months DAPT (p=0.026).26 T
this evidence was confirmed in recent report
Table 3: Risk factors for stent thrombosis and bl
REFERENCES 1. Bangalore S et al. Short- and long
stents. JAMA. 2005;293(17):2126-30. 36. Vardi M e
DRUG-COATED BALLOONS AND CORONARY BIFURCATION
of both vessels. The provisional stent strategy i
Table 1 continued. Name Year of publication Type
DRUG-COATED BALLOONS IN BIFURCATION LESIONS As p
REFERENCES 1. Louvard Y et al. Classification of
PERCUTANEOUS CORONARY INTERVENTION FOR CHRO
Presence of symptoms Yes
GENERAL ASPECTS IN CHRONIC TOTAL OCCLUSION LESION
There are sex differences: 80% of patients with C
1 Dual injection 2 1. Ambiguous proximal c
Finally, remember that time constraint in t
higher after DES of CTO compared to non-CTO, at l
The Mehran score74 suggested that ‘very high-risk
compared with a successful percutaneous CTO
J Am Coll Cardiol. 1993;22(7):1755-62. 21. Grine
intervention in chronic total occlusions caused
UPCOMING EVENTS SOLACI-CACI ‘17: 23rd Annual Meet
INTERVENTIONAL CARDIOLOGY PCR London Valves 2017
Buyer’s Guide • AACHEN RESONANCE • ABBOTT •
Interventional Cardiology • LEPU MEDICAL TECH
SUBSCRIBE TO RECEIVE THE LATEST PUBLICATIONS, NEW